Literature DB >> 9066323

Electrocardiographic and hemodynamic changes and their association with myocardial infarction during coronary artery bypass surgery. A multicenter study. Multicenter Study of Perioperative Ischemia (McSPI) Research Group.

U Jain1, C J Laflamme, A Aggarwal, J G Ramsay, M E Comunale, S Ghoshal, L Ngo, K Ziola, M Hollenberg, D T Mangano.   

Abstract

BACKGROUND: Electrocardiographic (ECG) changes during coronary artery bypass graft surgery have not been described in detail in a large multicenter population. The authors describe these ECG changes and evaluate them, along with demographic and clinical characteristics and intraoperative hemodynamic alterations, as predictors of myocardial infarction (MI) as defined by two sets of criteria.
METHODS: Data from 566 patients at 20 clinical sites, collected as part of a clinical trial to evaluate the efficacy of acadesine for reducing MI, were analyzed at core laboratories. Perioperative ECG changes were identified using continuous three-lead Holter ECG. Systolic blood pressure, diastolic blood pressure, and heart rate were recorded each minute during operation. The occurrence of MI by Q wave or myocardial fraction of creatine kinase (CK-MB) or autopsy criteria, and by (Q wave and CK-MB) or autopsy criteria was determined.
RESULTS: During perioperative Holter monitoring, episodes of ST segment deviation, major cardiac conduction changes > or = 30 min, or use of ventricular pacing > or = 30 min occurred in 58% patients, primarily in the first 8 h after release of aortic occlusion. Of the 25% patients who met the Q wave or CK-MB or autopsy criteria for MI, 19% had increased CK-MB as well as ECG changes. (Q wave and CK-MB) or autopsy criteria for MI were met by 4% of patients. The CK-MB concentration generally peaked by 16 h after release of aortic occlusion. In patients with (n = 187) and without a perioperative episode of ST segment deviation, the incidence of MI was 36% and 19%, respectively (P < 0.01), by Q wave or CK-MB or autopsy criteria, and 6% and 3%, respectively (P = 0.055), by (Q wave and CK-MB) or autopsy criteria. Multiple logistic regression analysis showed that intraoperative ST segment deviation, intraventricular conduction defect, left bundle branch block, duration of hypotension (systolic blood pressure < 90 mmHg) after cardiopulmonary bypass, and duration of cardiopulmonary bypass are independent predictors of Q wave or CK-MB or autopsy MI. The independent predictors of (Q wave and CK-MB) or autopsy MI are intraoperative ST segment deviation and duration of aortic occlusion.
CONCLUSIONS: Major ECG changes occurred in 58% of patients during coronary artery bypass graft surgery, primarily within 8 h after release of aortic occlusion. Multicenter data collection revealed a substantial variation in the incidence of MI and an overall incidence of up to 25%, with most MI occurring within 16 h after release of aortic occlusion. Intraoperative monitoring of ECG and hemodynamics has incremental value for predicting MI.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9066323     DOI: 10.1097/00000542-199703000-00009

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  9 in total

1.  Simplified detection of myocardial ischemia by seismocardiography. Differentiation between causes of altered myocardial function.

Authors:  M Becker; A B Roehl; U Siekmann; A Koch; M de la Fuente; R Roissant; K Radermacher; N Marx; M Hein
Journal:  Herz       Date:  2013-06-23       Impact factor: 1.443

2.  Cardiopulmonary Complications Following Cardiac Surgery.

Authors:  Renée L. Quarterman; Arthur Wallace; Mark B. Ratcliffe
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-04

3.  Impact of intraoperative hypotension on hospital stay in major abdominal surgery.

Authors:  Vassilios Tassoudis; George Vretzakis; Argyro Petsiti; Georgia Stamatiou; Katerina Bouzia; Michael Melekos; George Tzovaras
Journal:  J Anesth       Date:  2011-05-06       Impact factor: 2.078

4.  Perioperative myocardial infarction diagnosis after coronary artery bypass grafting surgery using coupled electrocardiographic changes and cardiac troponin I.

Authors:  Arvin Shahzamani; Erfan Sheikhbahaei; Shahab Shahabi; Mehran Shahzamani; Helia Hemasian; Niayesh Hadi; Sara Zamani
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2018-08-28

5.  Troponin is superior to electrocardiogram and creatinine kinase MB for predicting clinically significant myocardial injury after coronary artery bypass grafting.

Authors:  Jochen D Muehlschlegel; Tjörvi E Perry; Kuang-Yu Liu; Luigino Nascimben; Amanda A Fox; Charles D Collard; Edwin G Avery; Sary F Aranki; Michael N D'Ambra; Stanton K Shernan; Simon C Body
Journal:  Eur Heart J       Date:  2009-04-30       Impact factor: 29.983

6.  Predictors and timing of hypotension and bradycardia after carotid artery stenting.

Authors:  P Lavoie; J Rutledge; M A Dawoud; M Mazumdar; H Riina; Y P Gobin
Journal:  AJNR Am J Neuroradiol       Date:  2008-08-21       Impact factor: 3.825

7.  Whole blood transcriptomics in cardiac surgery identifies a gene regulatory network connecting ischemia reperfusion with systemic inflammation.

Authors:  Orfeas Liangos; Sophie Domhan; Christian Schwager; Martin Zeier; Peter E Huber; Francesco Addabbo; Michael S Goligorsky; Lynn Hlatky; Bertrand L Jaber; Amir Abdollahi
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

8.  Obesity & hypertension are determinants of poor hemodynamic control during total joint arthroplasty: a retrospective review.

Authors:  Benedict U Nwachukwu; Jamie E Collins; Emily P Nelson; Mercedes Concepcion; Thomas S Thornhill; Jeffrey N Katz
Journal:  BMC Musculoskelet Disord       Date:  2013-01-14       Impact factor: 2.362

9.  Haemodynamic Responses to Tracheal Intubation Using Propofol, Etomidate and Etomidate-Propofol Combination in Anaesthesia Induction.

Authors:  Özgür Yağan; Nilay Taş; Ahmet Küçük; Volkan Hancı; Bülent Serhan Yurtlu
Journal:  J Cardiovasc Thorac Res       Date:  2015-11-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.